(Q46753895)

24 December 2017

title

Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity (English)

1 reference

24 December 2017

author

Tomáš Šimůnek

1

1 reference

24 December 2017

author name string

Martin Sterba

2

1 reference

24 December 2017

Olga Popelova

3

1 reference

24 December 2017

Helena Kaiserova

4

1 reference

24 December 2017

Anna Potacova

5

1 reference

24 December 2017

Michaela Adamcova

6

1 reference

24 December 2017

Yvona Mazurova

7

1 reference

24 December 2017

Premysl Ponka

8

1 reference

24 December 2017

Vladimir Gersl

9

1 reference

24 December 2017

publication date

1 January 2008

1 reference

24 December 2017

published in

Hemoglobin

1 reference

24 December 2017

volume

32

1 reference

24 December 2017

issue

1-2

1 reference

24 December 2017

page(s)

207-215

1 reference

24 December 2017

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

The evolution of iron chelators for the treatment of iron overload disease and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

Deferiprone protects against doxorubicin-induced myocyte cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

Deferiprone protects the isolated atria from cardiotoxicity induced by doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

HPLC study on stability of pyridoxal isonicotinoyl hydrazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680276

10.1080/03630260701680276

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18274998

1 reference

24 December 2017